Zimmer H G, Kolbeck-Ruhmkorff C, Zierhut W
Department of Physiology, University of Munich, Germany.
Cardioscience. 1995 Mar;6(1):47-57.
The aim of the study was to examine whether stimulation of alpha- and beta-adrenergic receptors in intact rats induces cardiac hypertrophy and to characterize the metabolic alterations that precede or accompany the process of hypertrophy. Cardiac beta-adrenergic receptors were stimulated with a single subcutaneous injection of 25 mg/kg isoproterenol. This led to an increase in the cardiac cAMP level which was followed by the sequential enhancement of adenine nucleotide biosynthesis and protein synthesis. The increase in adenine nucleotide and protein synthesis induced by isoproterenol was prevented by propranolol (50 mg/kg) within the first 5 hours. Norepinephrine, given as a continuous intravenous infusion of 0.2 mg/kg for 3 days, induced an increase in heart rate, mean aortic pressure and total peripheral resistance. Cardiac output was slightly reduced. The cardiac RNA/DNA ratio and the left ventricular weight/body weight ratio were significantly increased by about 40%. Simultaneous intravenous administration of the alpha-receptor blocker prazosin (0.1 mg/kg/h) and of the beta-receptor blocker metoprolol (1 mg/kg/h) reversed the functional changes and attenuated the increase in the RNA/DNA ratio induced by norepinephrine. The left ventricular weight/body weight ratio was within the range of the control values. Selective stimulation of alpha-adrenergic receptors by continuous intravenous infusion of norfenephrine (2 mg/kg/h) for 3 days increased heart rate and total peripheral resistance, while cardiac output was significantly lower. The RNA/DNA and left ventricular weight/body weight ratios were increased. Prazosin attenuated the increase in the RNA/DNA ratio induced by norfenephrine and prevented the development of cardiac hypertrophy. In the isolated perfused working rat heart, norepinephrine (3 x 10(-8) M) increased the expression of the proto-oncogenes c-fos and c-myc after 30 and 60 minutes, respectively. This increase occurred at about the same time as that induced by volume overload (increase of preload from 8 to 16 cm H2O) and pressure overload (increase of afterload from 80 to 100 cm H2O), but was more pronounced. In intact rats, norepinephrine elicited an increase in the mRNA and activity of glucose-6-phosphate dehydrogenase, the first and regulating enzyme of the oxidative pentose phosphate pathway, in a time-dependent manner. It is suggested that this may be part of a long-term homeostatic mechanism to keep the cardiac adenine nucleotide level in the normal range.
本研究的目的是检验在完整大鼠体内刺激α和β肾上腺素能受体是否会诱发心肌肥大,并描述在肥大过程之前或伴随该过程的代谢变化。通过皮下单次注射25mg/kg异丙肾上腺素来刺激心脏β肾上腺素能受体。这导致心脏cAMP水平升高,随后依次出现腺嘌呤核苷酸生物合成和蛋白质合成的增强。异丙肾上腺素诱导的腺嘌呤核苷酸和蛋白质合成增加在最初5小时内被普萘洛尔(50mg/kg)阻止。去甲肾上腺素以0.2mg/kg的剂量持续静脉输注3天,可导致心率、平均主动脉压和总外周阻力增加。心输出量略有降低。心脏RNA/DNA比值和左心室重量/体重比值显著增加约40%。同时静脉给予α受体阻滞剂哌唑嗪(0.1mg/kg/h)和β受体阻滞剂美托洛尔(1mg/kg/h)可逆转功能变化,并减弱去甲肾上腺素诱导的RNA/DNA比值升高。左心室重量/体重比值在对照值范围内。通过持续静脉输注去氧肾上腺素(2mg/kg/h)3天选择性刺激α肾上腺素能受体,可使心率和总外周阻力增加,而心输出量显著降低。RNA/DNA和左心室重量/体重比值升高。哌唑嗪减弱了去氧肾上腺素诱导的RNA/DNA比值升高,并阻止了心肌肥大的发展。在离体灌注的工作大鼠心脏中,去甲肾上腺素(3×10⁻⁸M)分别在30分钟和60分钟后增加了原癌基因c-fos和c-myc的表达。这种增加与容量超负荷(前负荷从8cm H₂O增加到16cm H₂O)和压力超负荷(后负荷从80cm H₂O增加到100cm H₂O)诱导的增加大致同时出现,但更为明显。在完整大鼠中,去甲肾上腺素以时间依赖性方式使磷酸戊糖氧化途径的第一个调节酶葡萄糖-6-磷酸脱氢酶的mRNA和活性增加。提示这可能是使心脏腺嘌呤核苷酸水平保持在正常范围内的长期稳态机制的一部分。